Pharmacologic Issues in Geriatric Emergency Medicine

Emergency Medicine Clinics of North America

Volumn 24, Issue 2, 2006, Pages 449-465

  Blanda, Michelle P ^a  

^a SUMMA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; ASCORBIC ACID; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISACODYL; CALCIUM; CARDIOTONIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GLUCOSAMINE; GUANETHIDINE; HERBACEOUS AGENT; HYLORAL; IMMUNOSUPPRESSIVE AGENT; METHYLDOPA; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROPRANOLOL DERIVATIVE; SABAL EXTRACT; TRIMETHOBENZAMIDE; UNINDEXED DRUG; VITAMIN D; WARFARIN;

AGING; AGITATION; ALZHEIMER DISEASE; ANGINA PECTORIS; ANTICHOLINERGIC EFFECT; ASPIRATION; BLEEDING; BONE MARROW SUPPRESSION; BRADYCARDIA; CARDIOTOXICITY; COGNITIVE DEFECT; CONFUSION; CONSENSUS; DELIRIUM; DEMENTIA; DEPRESSION; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG ABUSE; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG METABOLISM; DRUG USE; DRY EYE; EMERGENCY MEDICINE; EXTRAPYRAMIDAL SYNDROME; FALLING; FLUID RETENTION; GASTROINTESTINAL HEMORRHAGE; GENERAL PRACTITIONER; HALLUCINATION; HEART ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEAT STROKE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; INTOXICATION; KIDNEY DISEASE; KIDNEY FAILURE; MEDICATION ERROR; MORTALITY; MYDRIASIS; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; PARKINSON DISEASE; PATIENT COMPLIANCE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QT PROLONGATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; STROKE; TARDIVE DYSKINESIA; THIRST; URINE RETENTION; WORLD HEALTH ORGANIZATION; XEROSTOMIA;

EID: 33645888422     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2006.01.007     Document Type: Review

References (60)

1. Principles of care and application of the geriatric emergency care model. In: Sanders A.B. (Ed). Geriatric Emergency Medicine Task Force: emergency care of the elder person (1996), Beverly Cracom Publications, St. Louis (MO)
2. Rochon P.A., and Gurwitz J.H. Drug therapy. Lancet 346 (1995) 32-36
3. Rochon P.A., and Gurwitz J.H. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315 (1997) 1096-1099
4. Department of Health and Human Services, Administration on Aging (AoA). Statistics-a profile of older americans; 2003 (available at: http://www.aoa.gov/prof/Statistics/profile/2003/2_pf.asp).
5. Kaufman D.W., Kelly J.P., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 287 3 (2002) 337-344
6. Chutka D.S., Takahashi P.U., and Hoel R.W. Inappropriate medications for elderly patients. Mayo Clin Proc 79 (2004) 122-139
7. Delafuente J.C. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48 (2003) 133-143
8. Stewart R.B., and Cooper J.W. Polypharmacy in the aged. Practical solutions. Drugs Aging 4 6 (1994) 449-461
9. World Health Organization (WHO). International drug monitoring: the role of the hospital (1966), World Health Organization, Geneva (Switzerland) (Technical Report Series No. 425)
10. Hepler C.D., and Strand L.M. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47 (1990) 533-543
11. Johnson J.A., and Bootman J.L. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med 155 (1995) 1949-1956
12. Crome P. What's different about older people. Toxicology 192 (2003) 49-54
13. Grandison M.K., and Boudinot F.D. Age-related changes in protein bindings of drugs: implications for therapy. Clin Pharmacokinet 38 3 (2000) 271-290
14. Zeeh J., and Platt D. The aging liver. Gerontology 48 (2002) 121-127
15. Hammerlein A., Derendorf H., and Lowenthal D.T. Pharmakokinetic and pharmacodynamic changes in the elderly. Clin Pharmacokinet 35 (1998) 49-64
16. Schmucker D.L., Woodhouse K.W., Wang R.K., et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 48 (1990) 365-374
17. Delafuente J.C. Arthritis. In: Delafuente J.C., and Stewart R.B. (Eds). Therapeutics in the elderly. 3rd ed. (2001), Harvey Whitney Books Co., Cincinnati (OH) 499-513
18. Whelton A., Stout R.L., Spilman P.S., et al. Renal effects of ibuprofen, prioxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. Ann Intern Med 112 (1990) 568-576
19. Swedko P.J., Clark H.D., Paramsothy K., et al. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 163 (2003) 356-360
20. Vuyk J. Pharmacodynamics in the elderly. Best Pract Res Clin Anaesthesiol 17 2 (2003) 207-218
21. Gardin J.M. Left ventricular diastolic function in the elderly. Am J Geriatr Cardiol 3 (1994) 32-41
22. Gardin J.M., Arnold A.M., Bild D.E., et al. Left ventricular diastolic filling in the elderly: the cardiovascular health study. Am J Cardiol 82 (1998) 345-351
23. Priebe H.J. The aged cardiovascular risk patient. Br J Anaesth 85 (2000) 763-778
24. Toescu E.C., and Verkhratsky A. Parameters of calcium homeostasis in normal neuronal ageing. J Anat 197 (2000) 563-569
25. Joseph J.A., Denisova N.A., Bielinski D.S., et al. Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention. Mech Ageing Dev 116 (2000) 141-153
26. Shields S.A., Gilson J.M., Blakemore W.F., et al. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28 (1999) 77-83
27. Col N., Fanale J.E., and Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150 (1990) 841-845
28. Lazarou J., Pomeranz B.H., and Corey P.N. Incidence of adverse drug reactions in hospitalized patients. JAMA 279 15 (1998) 1200-1205
29. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 2997;277(4):307-11.
30. Pirmohamed M., James S., Meakin S., et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329 (2004) 15-19
31. Akwagyriam I., Goodyer L.I., Harding L., et al. Drug history taking and the identification of drug related problems in an accident and emergency department. J Accid Emerg Med 13 (1996) 166-168
32. Rieger K., Scholer A., Arnet I., et al. High prevalence of unknown co-medication in hospitalised patients. Eur J Clin Pharmacol 60 (2004) 363-368
33. Chung M.K., and Bartfield J.M. Knowledge of prescription medications among elderly emergency department patients. Ann Emerg Med 39 6 (2002) 605-608
34. O'Connell M.B., and Johnson J.F. Evaluation of medication knowledge in elderly patients. Ann Pharmacother 26 (1992) 919-921
35. Blenkiron P. The elderly and their medication: understanding and compliance in a family practice. Postgrad Med J 72 (1996) 671-676
36. Wiffen P, Gill M, Edwards J, et al. Adverse drug reactions in hospital patients. Bandolier Extra 2002;1-15 (http://www.jr2.ox.ac.uk/bandolier/Extraforbando/ADPRM.PDF).
37. Gaspoz J.M., Coxson P.G., Goldman P.A., et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 346 (2002) 1800-1806
38. Gurwitz J.H., Fields T.S., Avorn J., et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 109 (2000) 87-94
39. Bootman J.L., Harrison D.L., and Cox E. The health care cost of drug-reltaed morbidity and mortality in nursing facilities. Arch Intern Med 157 (1997) 2089-2096
40. Gurwitz J.H., and Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 114 (1991) 956-966
41. Williamson J., and Chopin J.M. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 9 (1980) 73-80
42. Davidsen F., Haghfelt T., Gram L.F., et al. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol 34 (1988) 83-86
43. Carbonin P., Pahor M., Bernabei R., et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?. J Am Geriatr Soc 39 (1991) 1093-1099
44. Hajjar E.R., Hanlon J.T., Artz M.B., et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 1 2 (2003) 82-89
45. Routledge P.A., O'Mahony M.S., and Woodhouse K.W. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57 2 (2003) 121-126
46. Williams C.M. Using medications appropriately in older adults. Am Fam Physician 66 (2002) 1917-1924
47. Fouts M., Hanlon J., Pieper C., et al. Identification of elderly nursing facility residents at high risk for drug-related problems. Consult Pharm 12 (1997) 1103-1111
48. Skarupski K.A., Mrvos R., and Krenzelok E.P. A profile of calls to a poison information center regarding older adults. J Aging Health 16 2 (2004) 228-247
49. Beers M.H., Ouslander J.G., Rollingher I., et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med 151 (1991) 1825-1832
50. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 157 (1997) 1531-1536
51. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers Criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163 (2003) 2716-2724
52. Alliance for Aging Research and the American Society of Consultant Pharmacists. When medicine hurts instead of helps: preventing medication problems in older persons. Available at: http://ascp.com/medhelp/.
53. Lanza F.L., Umbenhauer E.R., Melsom R.S., et al. A double blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers. J Rheumatol 9 (1982) 415-419
54. Goulding M.R. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 164 (2004) 305-312
55. Anderson W.K., and Wahler R. Pharmacy management can reduce Medicare-and human costs. Aging Today January/February (2001)
56. Hanlon J.T., Lindblad C.I., and Gray S.L. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?. Am J Geriatr Pharmacother 2 1 (2004) 3-13
57. McDonnell P.J., and Jacobs M.R. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36 (2002) 1331-1336
58. Schmader K.E., Hanlon J.T., Pieper C.F., et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116 (2004) 394-401
59. Rich M.W., Beckham V., Wittenberg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Eng J Med 333 (1995) 1190-1195
60. Le Couteur D.G., Hilmer S.N., Glasgow N., et al. Prescribing in older people. Aust Fam Physician 33 10 (2004) 777-781